| ¿µ¹® | risk factor | ÇÑ±Û | À§ÇèÀÎÀÚ |
|---|---|---|---|
| ¼³¸í | ±¹Á¦¹æ»ç¼±¹æÈ£À§¿øÈ¸(ICRP)°¡ 1977³â ±Ç°í¿¡¼ ¹æ»ç¼±¹æÈ£ÀÇ ¸ñÀûÀ¸·Î äÅÃÇÑ Áö¼ö·Î, ´ÜÀ§¼±·®(1 Sv)´ç È®·üÀû ¿µÇâÀÇ ¹ß»ýÈ®·üÀ» ÃßÁ¤ÇÏ¿© ³ªÅ¸³½ °ÍÀÌ´Ù. »ý½Ä¼± ¼±·®¿¡ ´ëÇÑ À¯ÀüÀû¿µÇâÀÇ ¹ß»ý·ü(4¡¿10£3/Sv)À̳ª Àû»ö°ñ¼ö¼±·®¿¡ ´ëÇÑ ¹éÇ÷º´ ¹ß»ý·ü(2¡¿10£3/Sv)µî ¿Ü¿¡ »À, ÇãÆÄ, °©»ó»ù, Á¥»ù, ±âŸ Á¶Á÷ÀÇ À§ÇèÁö¼ö¸¦ ÃøÁ¤ÇÏ¿©, È®·üÀû ¿µÇâÀÇ Àü½Å¿¡ ÀÖ¾î¼ Ä¡»çÀ§ÇèÁö¼öÀÇ Çհ踦 16.5¡¿10£3/Sv·Î ÇÏ¿´´Ù. ±×ÈÄ ICRP´Â 1990³â ±Ç°í¿¡¼ ´ë»óÀÌ µÇ´Â Á¶Á÷°ú Àå±â¸¦ Ãß°¡Çϰí, ¼öÄ¡ °³Á¤À» ÇÏ¸é¼ ¸íεµ °¢¸ñÀûÈ®·üÁö¼ö¶ó°íÇÏ¿´´Ù. ÀÌ ±Ç°í¿¡ ÀÇÇϸé, Ä¡»çÀû È®·üÀû ¿µÇâÀÇ È®·üÁö¼öÀÇ ÇÕ°è´Â, ÀϹÝÀο¡ ÀÖ¾î 60.0¡¿10£3/SvÀÌ´Ù. |
||
| ¿µ¹® | premature infant | ÇÑ±Û | ¹Ì¼÷¾Æ, Á¶»ê¾Æ |
|---|---|---|---|
| ¼³¸í | »ýÁ¸°¡´É ÇѰè ÀÌÈÄ¿¡, Á¤±â Ãâ»êÀÇ ½Ã±â ÀÌÀü¿¡ ÀÚ¿¬ÀûÀ̰ųª ÀΰøÀûÀ¸·Î ºÐ¸¸ÇÏ´Â °ÍÀ» Á¶»êÀ̶ó°í Çϸç, ±× °á°ú ÅÂ¾î³ ¾ÆÀ̸¦ Á¶»ê¾Æ¶ó°í ¸»ÇÑ´Ù. WHO¿¡¼´Â 28~37ÁÖ¿¡ ÅÂ¾î³ ¾Æ±â¶ó°í Á¤ÀÇÇϰí ÀÖ´Ù. ÇöÀç »ýÁ¸°¡´É ÇѰè´Â ÀÇ·á±â¼úÀÇ Áøº¸¿¡ ÀÇÇØ ±× ÇѰ迪ÀÌ ³ÐÇôÁö°í ÀÖ´Ù. Á¶»ê¾ÆÀÇ ´ëºÎºÐÀº ÀúüÁß¾Æ(2,500g ÀÌÇÏ)·Î Ãâ»ýÇϱ⠶§¹®¿¡ °¢ Àå±â±â´ÉÀÌ ÃæºÐÇÏ°Ô ¼º¼÷µÇ¾î ÀÖÁö ¾Ê¾Æ »ýÈÄ¿¡ È£Èí, °£, ÄáÆÏ µîÀÇ ±â´ÉÀå¾Ö¸¦ ¹ß»ýÇÏ´Â ÀÏÀÌ ¸¹´Ù. º¸À°±â¿¡ ÀÇÇÑ °ü¸®°¡ ÇÊ¿äÇÑ °æ¿ìµµ ÀÖ´Ù. ¾î¸®°Å³ª ³ªÀÌ ¸¹Àº ÀÓºÎÀÇ Ãʻ꿡 ¸¹´Ù. |
||
| ¿µ¹® | newborn infant | ÇÑ±Û | ½Å»ý¾Æ |
|---|---|---|---|
| ¼³¸í | ºÐ¸¸ Á÷ÈĺÎÅÍ µ¶¸³µÈ ÀÚ±ÃÀÇ »ýȰÀ» ÇÒ ¼ö ÀÖ´Â ´É·ÂÀ» ȹµæÇÒ ¶§±îÁöÀÇ ¾ÆÀÌ. ½Å»ý¾Æ´Â »ýÈÄ 4ÁÖÀϱîÁö¸¦ ¸»ÇÑ´Ù. ÀÌ ±â°£¿¡ ½Å»ý¾Æ´Â ¸ðüÀÇ Å ¾È¿¡¼ ÀÚµ¿ÀûÀ¸·Î »ê¼Ò³ª ¿µ¾çÀ» ¹Þ°í ÀÖ´ø »óÅ¿¡¼ ÀÚ·ÂÀ¸·Î È£ÈíÀ̳ª ¿µ¾ç ¼·Ã븦 ÇÏ°Ô µÇ´Â ±Þ°ÝÇÑ º¯È°¡ ÀϾ°í, ÀÌ¿¡ µû¶ó¼ ÃʱâÀÇ Ã¼¿ÂÀÇ °ÇÏ, »ý¸®Àû üÁßÀÇ °¨¼Ò, ½Å»ý¾ÆÈ²´Þ, ÅÈÁÙÀÇ Å»¶ô µîÀÇ ¿©·¯ Çö»óÀÌ ÀϾÙ. °¨°¢¸é¿¡¼´Â ¿µ¾ç ¼·Ã븦 À§ÇÑ ÈíÀιݻç´Â Àß ¹ß´ÞµÇ¾î ÀÖÀ¸³ª, ¹Ì°¢Àº ´ë°ÀÇ ¸ÀÀÇ ÆÇº°, Èİ¢Àº °ÇÑ ¾ÇÃë¿¡ ´ëÇÑ ¹ÝÀÀ, ½Ã°¢Àº ¸í¾ÏÀ» ÆÇº°ÇÏ´Â Á¤µµÀ̸ç, û°¢Àº »ýÈÄ 1ÁÖÀϰæ±îÁö´Â °ÅÀÇ ¹ÝÀÀÀ» ³ªÅ¸³»Áö ¾Ê´Â´Ù. |
||
| ¿µ¹® | infant | ÇÑ±Û | ¿µ¾Æ, À¯¾Æ, Á¥¸ÔÀÌ |
|---|---|---|---|
| ¼³¸í | ½Å»ý¾Æ¸¦ Æ÷ÇÔÇØ Ãâ»ý ÈÄ 1³â±îÁöÀÇ ¾î¸°À̸¦ ¸»Çϸç ÀÌ ±â°£À» ¿µ¾Æ±â¶ó ºÎ¸¥´Ù. ½Åü¹ßÀ° ¹× ¿îµ¿±â´ÉÀÇ ¹ß´ÞÀÌ ¸Å¿ì Ȱ¹ßÇÑ ½Ã±âÀÌ´Ù. ÀÌ ½Ã±â´Â ½Å»ý¾Æ ¶§ºÎÅÍ °è¼ÓÇØ¼ ȯ°æ¿¡ ÀûÀÀÇØ °¡´Â Áß¿äÇÑ ½Ã±âÀÌ´Ù. Á¥´Ï°¡ ³ª¿À¸ç ¸é¿ª±â´ÉÀÇ È°¼ºÈ, ¹Ý»çÀÇ ¼Ò½Ç°ú ¼öÀǿÀÇ ¹ß´Þ, °¨°¢(½Ã°¢, û°¢, Ã˰¢) ±â´ÉÀÇ ¹ß´Þ, üÁß°ú ŰÀÇ Áõ°¡¸¦ È®ÀÎÇÒ ¼ö ÀÖ´Ù. üÁßÀº 3°³¿ù¿¡ 2¹è, 1³â¿£ 3¹è°¡ µÇ¸ç, Ű´Â 1³â¿¡ ¾à 27cm ÀÚ¶õ´Ù. |
||
| ¿µ¹® | sudden infant death syndrome | ÇÑ±Û | ¿µ¾Æ±Þ»çÁõÈıº |
|---|---|---|---|
| ¼³¸í | ÇÑ »ì ÀÌÇÏÀÇ °Ç°ÇÑ ¾Æ±â°¡ ¾Æ¹«·± Á¶ÁüÀ̳ª ¿øÀÎ ¾øÀÌ °©Àڱ⠻ç¸ÁÇßÀ» °æ¿ì¿¡ ³»¸®´Â Áø´ÜÀÌ´Ù. ÀÌ ÁõÈıºÀº »ýÈÄ 1~4°³¿ù »çÀÌ¿¡ °¡Àå ¸¹ÀÌ ¹ß»ýÇϸç, ´ëºÎºÐ ¹ã 10½Ã¿¡¼ ¿ÀÀü 10½Ã »çÀÌ¿¡ ¹ß»ýÇÑ´Ù. Á¶»êÇϰųª ºÎ¸ð°¡ Èí¿¬ÀÚÀÏ °æ¿ì, 20¼¼ ÀÌÇÏ »ê¸ðÀÇ ÃÊ»ê, ÀÓ½ÅÀü °Ç°°ü¸®¿¡ ¼ÒȦÇÑ »ê¸ð¿¡°Ô¼ ÅÂ¾î³ ¿µ¾Æ¿¡°Ô¼ ¸¹ÀÌ ¹ß»ýÇÑ´Ù. ÀÌ ÁõÈıºÀ¸·Î »ç¸ÁÇÑ ¿µ¾ÆÀÇ ÇüÁ¦ÀÏ °æ¿ì ÀϹÝÀûÀÎ ¿µ¾Æº¸´Ù °É¸± È®·üÀÌ ³ôÀº °ÍÀ¸·Î ¾Ë·ÁÁ® ÀÖ´Ù. |
||
| HRP | high-risk patient; high-risk pregnancy; histidine-rich protein; horseradish peroxidase |
|---|---|
| IMR | individual medical record; infant mortality rate; infant mortality risk; Institute for Medical Resea... |
| HCG, hCG | Human Chorionic Gonadotropin; »ç¶÷À¶¸ð¼º¼º¼±ÀÚ±ØÈ£¸£¸ó 1. Placental Glycoprotein Hormone &nbs... |
| HP | halogen phosphorus; handicapped person; haptoglobin; hard palate; Harvard pump; health profession(al... |
| AR | absolute risk; accounts receivable; achievement ratio; actinic reticuloid [syndrome]; active resista... |
| HR | High Risk |
|---|---|
| BSID | Bayley Scale of Infant Development |
| IMR | Infant Mortality Rate |
| NMIHS | National Maternal and Infant Health Survey |
| SID | Sudden Infant Death |
| pregnancy, high-risk | Pregnancy in which the mother and/or foetus are at greater than normal risk of morbidity or mortality. Causes include lack of adequate prenatal care, previous obstetrical history, pre-existing maternal disease or pregnancy-induced disease, and multiple gestation, as well as advanced maternal age. (12 Dec 1998) |
|---|---|
| absolute risk | <statistics> The excess risk due to exposure to a specific hazard (disease, injury, etc.) (15 Jan 1998) |
| acceptable risk | <statistics> This relates to the potential for suffering disease or injury that will be tolerated by an individual, group, or society in exchange for the benefits of using a substance or process that will cause such disease or injury. Acceptability of risk depends on scientific data, social, economic, and political factors, and on the perceived benefits arising from a chemical or process that creates the risk in question. (15 Jan 1998) |
| attributable risk | The rate of a disease or other outcome in exposed individuals that can be attributed to the exposure. (05 Mar 2000) |
| cardiac risk | A term to describe overall risk of developing heart disease (blockage of the coronary arteries). Typical risk factors include: diabetes, high blood pressure, prior heart attack, high cholesterol, obesity, smoking and a family history for heart attacks in parents or siblings. (27 Sep 1997) |
| recurrence risk | In medical genetics, the recurrence risk is the chance that a genetic (inherited) disease present in the family will recur in that family and affect another person (or persons). It is the chance of lightning striking twice (or thrice, etc.). (12 Dec 1998) |
| glaucoma, risk factors | If you belong to a high-risk group for glaucoma, have your eyes examined through dilated pupils every 2 years by an eye care professional. High-risk groups include everyone with a family history of glaucoma, everyone over the age of 60 and any Black over the age of 40. (Among Blacks, studies show that glaucoma is: 5 times more likely to occur in Blacks than in Whites and about 4 times more likely to cause blindness in Blacks than in Whites). (12 Dec 1998) |
| relative risk | <epidemiology> The proportion of diseased people amongst those exposed to the relevant risk factor divided by the proportion of diseased people amongst those not exposed to the risk factor. This should be used in those cohort studies where those with and without disease are followed to observe which individuals become diseased. (05 Dec 1998) |
| risk | The probability that an event will occur. It encompasses a variety of measures of the probability of a generally unfavorable outcome. (12 Dec 1998) |
| risk assessment | The qualitative or quantitative estimation of the likelihood of adverse effects that may result from exposure to specified health hazards or from the absence of beneficial influences. (12 Dec 1998) |
| risk benefit | An analysis of risk versus benefit is a complex assessment that must be made by a physician prior to the administration of a particular form of drug therapy. Since many medications may have side effects that can be harmful (during the course of treatment), the overall risk of a particular form of drug therapy must be weighed against the overall threat of the untreated disease process (or treatment with an altenative drug). (27 Sep 1997) |
| risk factor | <statistics> A clearly defined occurrence or characteristic that has been associated with the increased rate of a subsequently occurring disease. (14 Oct 1997) |
| risk factors | An aspect of personal behaviour or lifestyle, environmental exposure, or inborn or inherited characteristic, which, on the basis of epidemiologic evidence, is known to be associated with a health-related condition considered important to prevent. (12 Dec 1998) |
| risk management | The process of minimizing risk to an organization by developing systems to identify and analyze potential hazards to prevent accidents, injuries, and other adverse occurrences, and by attempting to handle events and incidents which do occur in such a manner that their effect and cost are minimised. Effective risk management has its greatest benefits in application to insurance in order to avert or minimise financial liability. (12 Dec 1998) |
| risk of recurrence | In medical genetics, the chance that a genetic (inherited) disease present in a family will recur in that family. The concept in general medicine means the chance that an illness we come back again. (12 Dec 1998) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|